Stay updated on Inhibitors for COVID-19 Clinical Trial
Sign up to get notified when there's something new on the Inhibitors for COVID-19 Clinical Trial page.

Latest updates to the Inhibitors for COVID-19 Clinical Trial page
- Check2 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedA new MATIS-related publication citation (Hazell et al., BMJ Open 2026) was added to the Publications section, and the page shows Revision: v3.4.2; a generic funding-status notice was removed.SummaryDifference0.4%

- Check38 days agoChange DetectedAdded a government funding lapse notice with operating-status guidance and updated the site revision to v3.4.1 (replacing v3.4.0).SummaryDifference0.4%

- Check45 days agoChange DetectedUI and metadata enhancements were implemented: a glossary toggle is shown, and the page now displays Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, and the Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check59 days agoChange DetectedAdministrative update: revision v3.3.4 was added and v3.3.3 was removed, with no impact on study content or user-facing functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check80 days agoChange DetectedRevision: v3.3.3 was added. HHS Vulnerability Disclosure and Revision: v3.3.2 were removed.SummaryDifference0.1%

Stay in the know with updates to Inhibitors for COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inhibitors for COVID-19 Clinical Trial page.